retatrutide trial results news Looking forward to when #retatrutide's Phase 3 will become available. There are are 4 planned TRIUMPH trials investigating retatrutide's efficacy in treating obesity and its complications: #type2diabetes #cardiovascular disease Lilly's triple agonist delivers up

Why GLP1 Patients Notice Skin Changes GLP1 medications have transformed the way we approach weight management and metabolic health

How GLP-1 Lowers Inflammation in the Body Although originally approved for diabetes, researchers discovered something important: GLP-1 medications consistently reduce inflammation in fat tissue, the gut, the blood vessels, and even the immune system

It seems to reduce body fat in several different ways , including by increasing GLP-1 production in your body

Glucagon-like peptide 1 receptor (GLP-1R) agonist relieved asthmatic airway inflammation via suppression of NLRP3 inflammasome activation in obese asthma mice model